Strengthen Your Value Story with HEOR
Tap into our expertise in health economics and outcomes research (HEOR).
HEOR is a field of research that provides real-world data and insights to demonstrate the clinical and economic value of pharmaceutical products and medical devices. Unlike clinical trials, which demonstrate safety and efficacy, our research helps demonstrate therapeutic value and impact.
Recent news and publications from Optum HEOR experts
Recent publication: Economic impact of applying the AASLD-IDSA simplified treatment algorithm on the real-world management of hepatitis C
Recent presentation: Patterns of Colorectal Cancer (CRC) Screening Rates among the Average Risk U.S. Population
Meet with us at upcoming events. Schedule now >
Providing actionable HEOR data to prove cost-effectiveness
See how we worked with a medical device company to prove their device was more cost-effective than the current standard of care.
Leaders with deep domain expertise and industry knowledge
Our capabilities and experience span many therapeutic areas, including oncology, infectious disease and cardiovascular disease. Get to know our leaders.
Explore therapeutic areas
Our therapeutic focus supports the development of disease-specific capabilities and infrastructure.
Cardiovascular Disease
Developing research to advance the treatment of CVD, including dysrhythmia, hypertension and heart failure
Central Nervous System and Behavioral Health
Offering insights in Alzheimer’s, dementia, depression, and more.
Diabetes and Other Endocrine Diseases
Gaining insight on diabetes and other endocrine conditions
Infectious Disease
Combining real-world data and extensive therapeutic expertise to showcase the value of ID therapies
Oncology and Immunology
Offering expertise in solid tumors, hematologic malignancies and other inflammatory conditions
Respiratory Disease
Supporting our clients in evidence generation for asthma, COPD and other respiratory disease products
Rare Disease
Reimagining services for rare disease and developing advanced therapies
Primary data collection
Focusing on real-world evidence generation through primary and secondary data
Explore our HEOR capabilities
Design and conduct studies to generate real-world evidence of the value of medications and medical devices.
Find our HEOR experts at upcoming events
Related content
Solve contract challenges for gene therapies
There are hurdles to overcome for value-based contracts to become widespread.
11 things life sciences leaders need to know
We identified 11 trends worth watching.
Preparing for the future of life sciences
Life sciences leaders are thinking differently with data.
Sleep treatment across the ages
Combining real-world data and primary research helps us better understand insomnia.
Complementary solutions
Assess the fit, develop metrics and track care outcomes over time.
Better understand diseases and drug development opportunities.
Derive evidence from the unmatched depth and scale of our data assets.